Precision Oncology
Your Trusted Partner in Precision Diagnostics
Fortrea has a comprehensive understanding of the diagnostic process, from analytical validation to clinical implementation.
Strategic Regulatory Support
Knowledgeable Diagnostics Global Project Team
Extensive expertise in In Vitro Diagnostics (IVD) Development, Drug-Device Development, Companion Diagnostics (CDx), and Imaging Diagnostics
Evolution of Liquid Biopsies in Clinical Practice
VideoFortrea’s precision oncology experts, part of our Diagnostic Center of Excellence provide the guidance and infrastructure you need to support your liquid biopsy trials.
A New Approach for Diagnostic Development
Successful healthcare product development hinges on innovation to make a real impact.
At Fortrea, we use this philosophy to develop the strategies and designs needed by our stakeholders we collaborate with.
Fortrea combines specialism in.
- Regulatory strategy and regulatory affairs
- Data management and Quality Systems
- Health Economics, Outcomes and Reimbursement (HEOR)
- Tokenization
- Pre-clinical (non-clinical) testing, rational clinical trial design and conduct, ease of use, training and adoption
Oncology diagnostic data experience
Discover the Depth of Fortrea Oncology
Explore how our oncology expertise spans the full spectrum—from biomarker-driven precision medicine to immunotherapies, targeted treatments, and advanced cell and gene therapies.
Insights
Get the latest updates from our Diagnostics Center of Excellence
Detecting the Undetectable: The Rising Potential of Liquid Biopsies in Oncology
In the past decade, a vial of blood has become a powerful window into cancer biology. Liquid biopsies, once limited to detecting specific mutations in advanced lung cancer, now offer a dynamic, real-time view of tumor genetics across multiple cancer types.
Read Detecting the Undetectable: The Rising Potential of Liquid Biopsies in Oncology
The importance of early integration of liquid biopsy to enhance oncology research
Download White Paper
Future directions in liquid biopsy technology
Recent technological advancements have dramatically improved the sensitivity of liquid biopsies, enabling earlier diagnosis, precise treatment selection and enhanced disease monitoring.
Read Future directions in liquid biopsy technology